Tuesday, February 7, 2023
Bringing the Latest in News Straight to Your Screen

Box Office: ‘No Time To Die’ Passes $700 Million Worldwide

By News Creatives Authors , in Business , at November 14, 2021

No Time to Die earned another $4.62 million in its sixth weekend of domestic release, dropping just 23% despite being available on PVOD as of this past Tuesday. The 25th official James Bond film crossed $150 million domestic, and with two straight holds like this it’ll likely top A Quiet Place part II ($160 million) to place fifth just below F9 ($173 million) for 2021. It’ll also pass the inflation-adjusted grosses of On Her Majesty’s Secret Service ($22 million in 1969/$155 million adjusted) and the unofficial 007 flick Never Say Never Again ($55 million in 1983/$161 million adjusted). Whether it ends up earning more domestically than Marvel’s Eternals (which will end with $165 million if it continues to leg like Black Widow) is an open question. But there’s nothing resembling competition for 007 until West Side Story in mid-December.

Inflation notwithstanding, an over/under $162 million cume would put it just ahead of Pierce Brosnan’s Die Another Day ($161 million in 2002) and behind only the four previous Daniel Craig 007 movies ($167 million in 2006, $168 million in 2008, $304 million in 2012 and $200 million in 2015) within the franchise. And if you offer up a 15% “due to Covid” loss, then a non-Covid figure would be around $185 million, both closer to Spectre and about in line with what might have been expected from a well-liked straight-up sequel to Spectre amid a more conventional marketplace. At “worst,” the “low” domestic figure will give Universal more bargaining power if they want to convince Amazon (MGM’s presumptive new owners) to let them distribute James Bond 26 worldwide. That’s because the Daniel Craig actioner is crushing it overseas.

Thanks to strong holds and an $8.2 million debut in Australia, No Time to Die earned $24 million overseas for a new $558 million foreign cume. That includes $58 million 17-day cume in China, meaning it’ll end between Skyfall ($61 million in 2012) and Spectre ($83 million in 2015) and $126 million in the United Kingdom (fifth all-time). The strong holds here and abroad were enough to push its global total past $700 million worldwide. That makes the Cary Fukunaga-directed actioner just the second Hollywood/non-Chinese release since 2019 to cross that milestone alongside Universal’s F9. With $708 million thus far, it should pass Fast & Furious 9’s $721 million cume, making it the biggest Hollywood release since Jumanji: The Next Level ($800 million), Star Wars: The Rise of Skywalker ($1.073 billion), Joker ($1.073 billion) and Frozen II ($1.45 billion) in late 2019.

Its $558 million overseas cume has now passed F9 ($549 million), while its “no China” $500 million overseas total still ranks behind of the worldwide totals of everything save for F9 since 2019. It has surpassed every Bourne movie, every Mission: Impossible save for Fallout ($792 million) and both Kingsman movies. It has grossed more than the combined respective global grosses of the Austin Powers trilogy ($676 million on a combined $116 million budget) and the Xander Cage/xXx trilogy ($683 million/$215 million). Among real-world action movies, it’ll soon be behind only Wolf Warrior II, Battle at Lake Changjin, Spectre, Skyfall, the last six Fast Saga flicks, Mission: Impossible 6 and (if you count them) the mostly superpower-free Dark Knight sequels. Among all 2020/2021 releases, it’ll soon sit behind Hi Mom ($837 million) and Battle at Lake Changjin ($885 million).

No Time to Die should end its global theatrical run with around $760 million, bigger than frankly anything else on the horizon (barring a happy miracle) save for Spider-Man: No Way Home in mid-December, The Batman in early March or (if Matt Reeves’ grimdark murder mystery reboot plays closer to Batman Begins than Amazing Spider-Man) Doctor Strange in the Multiverse of Madness in May. Whether $750 million-plus will be enough for MGM and Eon to break even in raw theatrical revenue (following two years of delays for the $250 million tentpole due to a director swap and then Covid), I’m guessing product placement deals and strong post-theatrical earnings will make everyone whole. Besides, the next one (with a new, cheaper Bond) will probably cost closer to $175 million and won’t have to deal with a global pandemic.


Leave a Reply

Your email address will not be published. Required fields are marked *